Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Ingredients

News in brief

FDA warns of fake Teva ADHD drug as shortage continues

30-May-2012

The FDA has warned patients about counterfeit versions of a Teva ADHD drug that is on the drug shortage list.

Lab tests run by the US Food and Drug Administration (FDA) show the Adderall (amphetamine and dextroamphetamine) bought online is devoid of the four official active pharmaceutical ingredients. Instead, the tablets contain tramadol and acetaminophen, APIs used in the treatment of acute pain.

API supply problems at Teva have put Adderall on the shortages list and the FDA says counterfeit drug producers may especially target treatments consumers are struggling to find legitimately. The FDA updated its shortages list two weeks ago to say Teva is still releasing Adderall when available.

Key Industry Events

 

Access all events listing

Our events, Events from partners...